Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
iRhythm (IRTC) reported Q2 revenue of $224.2M, up 20.1% YoY, beating estimates. ResMed (RMD) reported $1.46B in revenue, up 8.6% YoY, in line with expectations. Insulet (PODD) reported $801.7M in revenue, up 23.5% YoY, beating estimates but missing guidance. IRTC stock is down 4.4%, RMD up 3.4%, and PODD down 11.6% since reporting.
How this was made

The 30-second read
Why it matters
Earnings releases provide fresh data for short‑term trading decisions, though guidance variance creates mixed signals.
Market read
Earnings beats and misses across the sector create short‑term trading opportunities, but overall sentiment remains cautious.
What to watch
Potential supply‑chain constraints and upcoming regulatory reviews could affect future performance.
Background
The article compares Q2 results of three patient‑monitoring companies and provides brief market commentary.
Ticker impact
iRhythm reported Q2 revenue of $224.2M, up 20.1% YoY, beating estimates and raising guidance.
Potential modest price rally on earnings beat.
Revenue growth and beat suggest strength, but stock fell 4.4% post‑report.
ResMed posted Q2 revenue of $1.46B, up 8.6% YoY, in line with expectations, with a modest EPS beat.
Limited price movement expected.
Revenue in line and EPS beat, but stock rose only 3.4%.
Insulet reported Q2 revenue of $801.7M, up 23.5% YoY, beating estimates by 1.9% but missing next‑quarter guidance.
Possible short‑term pullback after price drop of 11.6%.
Revenue beat is positive, yet guidance miss and price decline suggest caution.
Market effects
Patient monitoring sector shows varied performance; growth in wearables but mixed guidance.
U.S. healthcare device stocks may see divergent moves based on individual earnings.
Limited to healthcare technology investors.
Counterpoint
Despite earnings beats, price declines suggest market skepticism on sustainability of growth.
Key entities
- companyiRhythm Technologies
Wearable cardiac monitoring device maker.
- companyResMed
Sleep apnea and respiratory disorder device manufacturer.
- companyInsulet
Insulin delivery system provider.



